ISOLERE BIO INC
Durham, NC · Biotech · Acquired
ViraTag™, a liquid-liquid phase separation platform for purifying AAV gene therapy vectors from cell culture media
isolerebio.com →- Grants
- $7.3M
- 14 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 1 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Chromatography-Free Antibody Purification by Affinity-Phase Separation | $223,951 | |
| Federal grant | Department of Health and Human Services · Phase I · Chromatography-Free Antibody Purification by Affinity-Phase Separation | $223,951 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Non-Chromatographic Method for the Purification of Monoclonal Antibodies | $269,999 | |
| Federal grant | Department of Health and Human Services · Phase II · Chromatography-Free Antibody Purification by Affinity-Phase Separation | $778,207 | |
| Federal grant | Department of Health and Human Services · Phase II · Chromatography-Free Antibody Purification by Affinity-Phase Separation | $1,500,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Chromatography-Free Antibody Purification by Affinity-Phase Separation | $721,793 | |
| Federal grant | Department of Health and Human Services · Phase II · ViraTag: A Scalable Purification Technology for Adeno-Associated Virus Gene Therapy Vectors | $224,890 | |
| Federal grant | Department of Health and Human Services · Phase I · Combined RNA Production and Purification Reagents Using Liquid-Liquid Phase Separating Biopolymers | $255,516 | |
| Federal grant | Department of Health and Human Services · Phase I · Combined RNA Production and Purification Reagents Using Liquid-Liquid Phase Separating Biopolymers | $255,516 | |
| Federal grant | Department of Health and Human Services · Phase I · LentiTag: A novel approach to the efficient manufacturing of active lentiviral vectors | $255,556 | |
| Federal grant | Department of Health and Human Services · Phase I · LentiTag: A novel approach to the efficient manufacturing of active lentiviral vectors | $255,556 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II:Non-Chromatographic Method for the Purification of Viral Vectors | $902,504 | |
| Federal grant | Department of Health and Human Services · Phase II · ViraTag: A Scalable Purification Technology for Adeno-Associated Virus Gene Therapy Vectors | $735,839 | |
| Federal grant | Department of Health and Human Services · Phase II · ViraTag: A Scalable Purification Technology for Adeno-Associated Virus Gene Therapy Vectors | $735,839 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2142 | CELLECHO INC | — | — |
| 2143 | Calico | — | — |
| 2144 | Scinai Immunotherapeutics Ltd. | — | $3.0M |
| 2145 | ISOLERE BIO INC | — | — |
| 2146 | Origin Life Sciences, Inc. | — | $2.9M |
| 2147 | KALION, INC. | — | $6.7M |
| 2148 | VIRONGY, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compositions Comprising Aav-binding Polypeptides And Methods Of Using The Sameapplication
- Protein-based Purification Matrices And Methods Of Using The Samegranted
- Protein-based Purification Matrices And Methods Of Using The Sameapplication
- Protein-based Purification Matrices And Methods Of Using The Sameapplication
- Genetically Encoded Polypeptide For Affinity Capture And Purification Of Biologicsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.